Careers  |  Sign In  |  Register  |   Twitter

New Cholesterol Drugs In Development May Reduce Heart Attacks and Strokes

The New York Times reports that two experimental cholesterol drugs, one being developed by Amgen and the other by Sanofi and Regeneron Pharmaceuticals have already been shown to lower bad cholesterol, and may also protect against heart attacks, strokes and other cardiovascular events. Early studies found that both drugs reduced the overall risk for cardiovascular events by about half, but researchers noted that the studies were actually intended to test how effective the drugs were in reducing cholesterol levels and not whether they reduced heart attacks, so specific research would still need to be conducted. Both drugs are reducing LDL cholesterol to lower levels than previous medications ever have, and may receive FDA approval as early as this summer.

Read the article published in The New York Times.